FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2221465226> ?p ?o ?g. }

• W2221465226 endingPage "579" @default.
• W2221465226 startingPage "574" @default.
• W2221465226 abstract "Adiponectin is a key component in multiple metabolic pathways. Studies evaluating associations of adiponectin with clinical outcomes in older adults have reported conflicting results. We investigated the association of adiponectin with mortality and cardiovascular disease (CVD) morbidity in a young, multiethnic adult population. We analyzed data from participants in the Dallas Heart Study without baseline CVD who underwent assessment of total adiponectin from 2000 to 2002. The primary outcome of all-cause mortality was assessed over median 10.4 years of follow-up using multivariable-adjusted Cox proportional hazards models. Secondary outcomes included CVD mortality, major adverse cardiovascular and cerebrovascular events (MACCE), and heart failure (HF). The study cohort included 3,263 participants, mean age 43.4 years, 44% women, and 50% black. There were 184 deaths (63 CVD), 207 MACCE, and 46 HF events. In multivariable models adjusted for age, gender, race, hypertension, diabetes, smoking, high-density lipoprotein cholesterol-C, hyperlipidemia, high-sensitivity C-reactive protein level, estimated glomerular filtration rate, and body mass index, increasing adiponectin quartiles were positively associated with all-cause mortality Q4 versus Q1 (hazard ratio [HR] = 2.27; 95% confidence interval [CI] 1.47, 3.50); CVD mortality Q4 versus Q1 (HR = 2.43; 95% CI 1.15, 5.15); MACCE Q4 versus Q1 (HR = 1.71; 95% CI 1.13, 2.60); and HF Q4 versus Q1 (HR = 2.95; 95% CI 1.14, 7.67). Findings were similar with adiponectin as a continuous variable and consistent across subgroups defined by age, gender, race, obesity, diabetes, metabolic syndrome, or elevated high-sensitivity C-reactive protein. In conclusion, higher adiponectin was associated with increased mortality and CVD morbidity in a young, multiethnic population. These findings may have implications for strategies aimed at lowering adiponectin to prevent adverse outcomes. Adiponectin is a key component in multiple metabolic pathways. Studies evaluating associations of adiponectin with clinical outcomes in older adults have reported conflicting results. We investigated the association of adiponectin with mortality and cardiovascular disease (CVD) morbidity in a young, multiethnic adult population. We analyzed data from participants in the Dallas Heart Study without baseline CVD who underwent assessment of total adiponectin from 2000 to 2002. The primary outcome of all-cause mortality was assessed over median 10.4 years of follow-up using multivariable-adjusted Cox proportional hazards models. Secondary outcomes included CVD mortality, major adverse cardiovascular and cerebrovascular events (MACCE), and heart failure (HF). The study cohort included 3,263 participants, mean age 43.4 years, 44% women, and 50% black. There were 184 deaths (63 CVD), 207 MACCE, and 46 HF events. In multivariable models adjusted for age, gender, race, hypertension, diabetes, smoking, high-density lipoprotein cholesterol-C, hyperlipidemia, high-sensitivity C-reactive protein level, estimated glomerular filtration rate, and body mass index, increasing adiponectin quartiles were positively associated with all-cause mortality Q4 versus Q1 (hazard ratio [HR] = 2.27; 95% confidence interval [CI] 1.47, 3.50); CVD mortality Q4 versus Q1 (HR = 2.43; 95% CI 1.15, 5.15); MACCE Q4 versus Q1 (HR = 1.71; 95% CI 1.13, 2.60); and HF Q4 versus Q1 (HR = 2.95; 95% CI 1.14, 7.67). Findings were similar with adiponectin as a continuous variable and consistent across subgroups defined by age, gender, race, obesity, diabetes, metabolic syndrome, or elevated high-sensitivity C-reactive protein. In conclusion, higher adiponectin was associated with increased mortality and CVD morbidity in a young, multiethnic population. These findings may have implications for strategies aimed at lowering adiponectin to prevent adverse outcomes." @default.
• W2221465226 created "2016-06-24" @default.
• W2221465226 creator A5012700139 @default.
• W2221465226 creator A5022261349 @default.
• W2221465226 creator A5039789130 @default.
• W2221465226 creator A5050858268 @default.
• W2221465226 creator A5051212717 @default.
• W2221465226 creator A5069986121 @default.
• W2221465226 creator A5088995880 @default.
• W2221465226 date "2016-02-01" @default.
• W2221465226 modified "2023-10-16" @default.
• W2221465226 title "Relation of Adiponectin to All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events (from the Dallas Heart Study)" @default.
• W2221465226 cites W1502722534 @default.
• W2221465226 cites W1562891630 @default.
• W2221465226 cites W1960953991 @default.
• W2221465226 cites W1967543638 @default.
• W2221465226 cites W1968841841 @default.
• W2221465226 cites W1971068956 @default.
• W2221465226 cites W2006261931 @default.
• W2221465226 cites W2024121534 @default.
• W2221465226 cites W2051961630 @default.
• W2221465226 cites W2053046905 @default.
• W2221465226 cites W2055864845 @default.
• W2221465226 cites W2061812498 @default.
• W2221465226 cites W2065697164 @default.
• W2221465226 cites W2072526806 @default.
• W2221465226 cites W2110634414 @default.
• W2221465226 cites W2118191095 @default.
• W2221465226 cites W2126257565 @default.
• W2221465226 cites W2126521413 @default.
• W2221465226 cites W2131541226 @default.
• W2221465226 cites W2132681327 @default.
• W2221465226 cites W2138564232 @default.
• W2221465226 cites W2144223290 @default.
• W2221465226 cites W2144852094 @default.
• W2221465226 cites W2144968122 @default.
• W2221465226 cites W2150389154 @default.
• W2221465226 cites W2151852249 @default.
• W2221465226 cites W2154838605 @default.
• W2221465226 cites W2160234571 @default.
• W2221465226 cites W2162422100 @default.
• W2221465226 cites W2163769778 @default.
• W2221465226 cites W2607031541 @default.
• W2221465226 doi "https://doi.org/10.1016/j.amjcard.2015.11.067" @default.
• W2221465226 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4737987" @default.
• W2221465226 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26800774" @default.
• W2221465226 hasPublicationYear "2016" @default.
• W2221465226 type Work @default.
• W2221465226 sameAs 2221465226 @default.
• W2221465226 citedByCount "33" @default.
• W2221465226 countsByYear W22214652262016 @default.
• W2221465226 countsByYear W22214652262017 @default.
• W2221465226 countsByYear W22214652262018 @default.
• W2221465226 countsByYear W22214652262019 @default.
• W2221465226 countsByYear W22214652262020 @default.
• W2221465226 countsByYear W22214652262021 @default.
• W2221465226 countsByYear W22214652262022 @default.
• W2221465226 countsByYear W22214652262023 @default.
• W2221465226 crossrefType "journal-article" @default.
• W2221465226 hasAuthorship W2221465226A5012700139 @default.
• W2221465226 hasAuthorship W2221465226A5022261349 @default.
• W2221465226 hasAuthorship W2221465226A5039789130 @default.
• W2221465226 hasAuthorship W2221465226A5050858268 @default.
• W2221465226 hasAuthorship W2221465226A5051212717 @default.
• W2221465226 hasAuthorship W2221465226A5069986121 @default.
• W2221465226 hasAuthorship W2221465226A5088995880 @default.
• W2221465226 hasBestOaLocation W22214652262 @default.
• W2221465226 hasConcept C126322002 @default.
• W2221465226 hasConcept C134018914 @default.
• W2221465226 hasConcept C164705383 @default.
• W2221465226 hasConcept C207103383 @default.
• W2221465226 hasConcept C2776782570 @default.
• W2221465226 hasConcept C2777391703 @default.
• W2221465226 hasConcept C2778198053 @default.
• W2221465226 hasConcept C2780221984 @default.
• W2221465226 hasConcept C2908647359 @default.
• W2221465226 hasConcept C44249647 @default.
• W2221465226 hasConcept C50382708 @default.
• W2221465226 hasConcept C511355011 @default.
• W2221465226 hasConcept C555293320 @default.
• W2221465226 hasConcept C71924100 @default.
• W2221465226 hasConcept C99454951 @default.
• W2221465226 hasConceptScore W2221465226C126322002 @default.
• W2221465226 hasConceptScore W2221465226C134018914 @default.
• W2221465226 hasConceptScore W2221465226C164705383 @default.
• W2221465226 hasConceptScore W2221465226C207103383 @default.
• W2221465226 hasConceptScore W2221465226C2776782570 @default.
• W2221465226 hasConceptScore W2221465226C2777391703 @default.
• W2221465226 hasConceptScore W2221465226C2778198053 @default.
• W2221465226 hasConceptScore W2221465226C2780221984 @default.
• W2221465226 hasConceptScore W2221465226C2908647359 @default.
• W2221465226 hasConceptScore W2221465226C44249647 @default.
• W2221465226 hasConceptScore W2221465226C50382708 @default.
• W2221465226 hasConceptScore W2221465226C511355011 @default.
• W2221465226 hasConceptScore W2221465226C555293320 @default.
• W2221465226 hasConceptScore W2221465226C71924100 @default.
• W2221465226 hasConceptScore W2221465226C99454951 @default.
• W2221465226 hasFunder F4320332161 @default.

• next